Mentor Worldwide

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Mentor Worldwide sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 8 completed later-stage tilt top decile by trial count

Mentor Worldwide: 11 sponsored US clinical trials, none currently recruiting.

Mentor Worldwide sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 8 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Revision, with 2 trials.

Top-decile sponsor footprint

Mentor Worldwide ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

11 total, page 1 of 1

ACTIVE NOT RECRUITING NA

Memory Gel and Shape Combined Cohort

NCT02919592
ACTIVE NOT RECRUITING NA

A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction

NCT02724371
COMPLETED Phase 3

CPG Styles Study: A Study of the Safety of the Contour Profile Gel Breast Implants (CPG Styles Study)

NCT01959880
TERMINATED Phase 4

Becker Continued Access Study

NCT01286870
COMPLETED Phase 3

A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows

NCT00752258
COMPLETED Phase 3

Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows

NCT00752050
COMPLETED Phase 3

Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows

NCT00752297
COMPLETED Phase 1

PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia

NCT00549341
COMPLETED Phase 3

PREVELLE Shape (CX002) Dermal Filler Protocol

NCT00764257
COMPLETED Phase 3

Mentor Siltex® Contour Profile Gel Mammary Prosthesis Clinical Trial

NCT00812097
COMPLETED Phase 3

Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses

NCT00753922

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 7
Phase 4 1

Therapeutic Areas

Breast Revision 2
Breast Augmentation 2
Breast Reconstruction 2
Correction of Nasolabial Folds and Lip Augmentation 1
Breast Reconstruction, Revision Breast Reconstruction 1
Revision Breast Reconstruction 1
Revision Breast Augmentation 1
Primary Breast Reconstruction 1
Primary Breast Augmentation 1

How the Mentor Worldwide archive is shaped

11 indexed studies, none listed as recruiting (0% open); 8 completed (73%).

Phase mix: 8 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Breast Revision (2 trials), 8 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Mentor Worldwide: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Mentor Worldwide sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Mentor WorldwideAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
Mentor Worldwide sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Mentor Worldwide sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Mentor Worldwide page

11 registered trials is a research-attention snapshot, not an endorsement of Mentor Worldwide or any single study.

  • None of Mentor Worldwide's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Breast Revision is the condition Mentor Worldwide studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Revision trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mentor Worldwide pipeline card: 11 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.